AKIN Criteria: Acute Kidney Injury After On-Pump Coronary Artery Bypass Graft (CABG)

Hospital de Base

Status: Completed

Conditions: Kidney Failure

Study type: Observational

Funder types: Other

Identifiers

NCT00780845

CAAE-3438.0.000.140-08

Details and patient eligibility

About

The purpose of this study is evaluate clinical outcomes and 30-day mortality after on-pump CABG.

Full description

Eight hundred and seventeen patients was enrolled in this series and divided into to groups: Group AKI (-) - patients without acute kidney injury after on-pump CABG. Group AKI (+) - patients with acute kidney injury after on-pump CABG. AKI was defined as an absolute increase in serum creatinine (SCr) of more than or equal to 0.3 mg/dl (≥ 26.4 μmol/l) or a percentage increase in SCr of more than or equal to 50% (1.5-fold from baseline). The change in SCr concentration was defined as the difference between immediate postoperative concentration and the highest concentration during the stay in ICU. Clinical Outcomes and 30-day mortality was evaluate in this patients.

Enrollment: 817 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients underwent on-pump coronary artery bypass grafting
• Patients with at least two serum creatinine values within 48 hours.

Exclusion criteria

• Patients with end-stage kidney disease requiring renal replacement therapy.

Trial design

817 participants in 2 patient groups

AKI (-)

Description:

Patients without acute kidney injury after on-pump CABG

AKI (+)

Description:

Patients with acute kidney injury after on-pump CABG